Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Le Coudray
Clinical trial register · France

Clinical Trials in Le Coudray, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 2823 Lyon 1395 Bordeaux 1389 Marseille 1291 Lille 1281
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novo Nordisk A/S6 Eli Lilly and Company5 Centre Hospitalier Régional d'Orléans2 AstraZeneca2 Rennes University Hospital1
Site location
Paris2823 Lyon1395 Bordeaux1389 Marseille1291 Lille1281
All 809 locations
Target enrolment
to

Trials with a site in Le Coudray

29 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Eli Lilly and Company
Phase 3
3,000
Corbeil-Essonnes, La Tronche, Le Coudray, Nantes, Paris, Pierre-Bénite, Poitiers, Rouen
2026-12
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Chambray-lès-Tours, Le Coudray, Lille, Massy, Paris, Pessac, Poitiers, Quint-Fonsegrives
2026-10-26
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Bron, Corbeil-Essonnes, La Tronche, Le Coudray, Lens, Metz-Tessy, Pau, Rennes
2026-08-24
Recruiting
Novo Nordisk A/S
Phase 3
450
Caen, Le Coudray, Lille, Vénissieux
2026-08-12
Not yet open
Intravenous Lidocaine for Hepatectomy
NCT07590830Hepatectomy
Rennes University Hospital
Phase 4
312
Clermont-Ferrand, La Roche-sur-Yon, Le Coudray, Lille, Lyon, Nice, Paris, Rennes
2026-08-01
Recruiting
Poitiers University Hospital
Not applicable
2,600
Angers, Grenoble, Le Coudray, Lille, Lyon, Marseille, Mont-de-Marsan, Nantes
2026-06-29
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bois-Guillaume, Colmar, Le Coudray, Paris, Pessac, Pierre-Bénite, Saint-Herblain, Vénissieux
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Bayonne, Bordeaux, Brest, Chambray-lès-Tours, Cholet, La Rochelle, Le Chesnay, Le Coudray
2026-05-11
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Bron, Chambray-lès-Tours, Compiègne, Grenoble, Le Coudray, Nantes, Paris, Toulouse
2026-05-11
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bois-Guillaume, Clermont-Ferrand, La Tronche, Le Coudray, Lyon, Mulhouse, Nantes, Nice
2025-12-01
Recruiting
Groupe Hospitalier du Havre
Not applicable
204
Le Havre, Le Coudray, Valence
2025-11-19
Recruiting
University Hospital, Angers
Not applicable
3,084
Chesnay, Angers, Caen, Cholet, La Roche-sur-Yon, La Rochelle, Le Coudray, Rouen
2025-09-19
Recruiting
Amgen
Phase 3
12,800
Besançon, Dijon, Grenoble, Le Coudray, Le Creusot, Lyon, Marseille, Nice
2025-07-25
Recruiting
Centre Hospitalier Régional d'Orléans
Not applicable
150
Orléans, Belfort, Clermont-Ferrand, Dax, Dijon, Le Coudray, Le Mans, Mont-de-Marsan
2025-07-04
Recruiting
Centre Hospitalier Régional d'Orléans
Not applicable
120
Orléans, La Roche-sur-Yon, Le Coudray, Nantes, Poitiers
2025-01-24
Recruiting
Biosency
Not applicable
380
Brest, Vannes, Le Coudray, Verdun, Lille, Montpellier, Toulouse, Marseille
2024-11-20
Recruiting
PulseSelect™ PFA Global Registry
NCT06393920Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
1,950
Grenoble, Le Coudray, Massy, Paris, Toulouse
2024-07-23
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Besançon, Bron, Caen, Chambray-lès-Tours, Corbeil-Essonnes, Grenoble, Le Coudray, Lille
2024-06-25
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bois-Guillaume, Bordeaux, Clermont-Ferrand, Corbeil-Essonnes, La Tronche, Le Coudray, Montpellier, Nantes
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
17,300
Bobigny, Bron, Chambray-lès-Tours, Compiègne, Dijon, Le Coudray, Lille, Lyon
2024-03-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Grenoble, Chambray-lès-Tours, Orléans, Dijon, Le Coudray, Nîmes, Limoges, Rennes
2023-10-09
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Annonay, Bobigny, Grenoble, Le Coudray, Le Havre, Lille, Montpellier, Paris
2023-03-01
Recruiting
AstraZeneca
Phase 3
3,527
Amiens, Angers, Brest, Créteil, Dijon, La Tronche, Le Coudray, Montpellier
2022-12-13
Active, closed
Eli Lilly and Company
Phase 3
15,374
Corbeil-Essonnes, La Tronche, Le Coudray, Le Creusot, Limoges, Nice, Paris, Pierre-Bénite
2022-10-11
Recruiting
MicroPort CRM
Observational
206
Bordeaux, Le Coudray, Marseille, Nantes, Toulouse, Valence
2022-03-25
Active, closed
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291Coronary Artery Disease, Coronary Artery Stenosis
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Not applicable
1,820
Essey-lès-Nancy, La Rochelle, Le Coudray, Nantes, Rouen, St-Malo
2021-11-16
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Pessac, Brest, Caen, La Roche-sur-Yon, Le Coudray, Marseille, Montpellier, Nîmes
2021-08-14
Recruiting
SCAD : a Registry of Spontaneous Coronary Artery Dissection
NCT06601270Spontaneous Coronary Artery Dissection
European Society of Cardiology
Observational
1,500
Besançon, Clermont-Ferrand, Le Coudray, Lyon, Massy, Pessac
2021-01-30
Recruiting
France PCI Registry : National Observatory of Interventional Cardiology
NCT02778724Interventional, Cardiology, Angioplasty, Coronary
Club Régional des Angioplasticiens de la région Centre
Observational
40,000
Le Coudray, Aurillac, Bourges, Caen, Chambray-lès-Tours, Clermont-Ferrand, Évreux, Le Havre
2014-01
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-france/city/le-coudray

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Le Coudray.

How many clinical trials are recruiting in Le Coudray?

17 of the 29 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 3 have not yet opened recruitment, 8 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Le Coudray), 29 studies
PhaseStudiesRecruitingShare
Phase 317758.6%
Not applicable7624.1%
Observational4413.8%
Phase 4103.4%

Most active sponsors

Lead sponsors with the most studies (Le Coudray)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S63
Eli Lilly and Company51
AstraZeneca22
Centre Hospitalier Régional d'Orléans22
Amgen11
Biosency11
Club Régional des Angioplasticiens de la région Centre11
European Society of Cardiology11
Fondazione Ricerca e Innovazione Cardiovascolare ETS10
Groupe Hospitalier du Havre11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.